On this page, explore how research drives progress in AHD care — with access to key studies, clinical trial results, guidelines, and insights shaping policy and practice across sub-Saharan Africa.
This page offers clinical resources, training tools, patient support, policy content, multimedia, and accessibility features — all designed to support comprehensive care and education.
Advanced HIV Disease, or AHD, happens when HIV has severely weakened the immune system. This makes it harder for the body to fight infections and increases the risk of serious illness, especially from conditions such as tuberculosis, cryptococcal meningitis and severe bacterial infections. According to the World Health Organisation, AHD is defined as:
A person can have AHD when they are first diagnosed with HIV, when they return to care after stopping treatment, or when HIV treatment is not working well. Many people only find out they have HIV when they become seriously ill.
Advanced HIV Disease (AHD) and Acquired Immunodeficiency Syndrome (AIDS) are closely related terms used to describe people with severe HIV-related immune suppression and a high risk of serious illness. Both are commonly associated with a CD4 count below 200 cells/mm³ and serious opportunistic infections. However, AHD is a broader concept.
AIDS refers to the most advanced stage of HIV infection and includes AIDS-defining illnesses.
Advanced HIV Disease (AHD) is the term used by the World Health Organisation to identify people who require enhanced HIV care. It includes adults and adolescents with a CD4 count below 200 cells/mm³ or WHO stage 3 or 4 disease, as well as all children under five years of age living with HIV who present for care. The concept of AHD recognizes that people may be at high risk of severe illness and death before developing AIDS-defining conditions. By identifying people earlier, health workers can provide targeted screening, diagnosis, treatment, and follow-up to prevent avoidable illness and death.
Today, AHD is widely used in HIV programs and clinical guidelines because it helps identify those most in need of urgent, comprehensive care.
🔴 Clinical diagnosis
WHO clinical and public health term
🔴 AIDS is the acronym of “Acquired Immunodefficiency syndrome”. It refers to the final and most advanced stage of HIV when it is not treated or when treatment has failed.
Refers to advance stage of HIV infection, characterized by severe immune suppression and/or presence of opportunistic infections.
When someone has advanced HIV disease (AHD), they are at high risk of serious infections and death. The STOP AIDS toolkit helps health workers deliver a package of care that can save lives. STOP = Screen. Treat. Optimise. Prevent.
Find out what’s going on.
Why it matters: Many people have serious infections that are not visible. These quick tests can catch them early.
Start the right treatment fast.
Why it matters: Delays in treatment can be deadly. Treat the infection immediately based on what’s found.
Start or restart HIV treatment quickly.
Why it matters: ART helps rebuild the immune system and prevent more infections but timing matters.
Stop future infections before they start.
Why it matters: Prevention saves lives. These simple meds can keep people from getting sick again.
The STOP AIDS Toolkit is endorsed by the World Health Organization and partners. When used together, these steps can reduce deaths from AHD by more than 25%.
When a person’s immune system is damaged by HIV, it can no longer fight off infections and diseases. At this stage, HIV has progressed to AHD. The immune system is weakened, leaving the body at risk for opportunistic infections (OIs), that take advantage of the weakened immune system.
Symptoms of AHD include:
Unexplained weight loss
Chronic diarrhea
Persistent fever and night sweats
Coughing and difficulty breathing
Extreme fatigue
These symptoms can also be signs of other conditions, which is why it’s important for healthcare workers to be trained in recognising AHD and opportunistic infections.
Anyone living with HIV can develop Advanced HIV Disease, but it usually occurs when HIV has been undiagnosed, left untreated or poorly managed.
People who don’t start HIV treatment early or don’t follow their treatment plan are more likely to develop AHD.
AHD is typically diagnosed in people with a low CD4 count (less than 200 cells/mm³) or those who have developed opportunistic infections.
People who don’t start HIV treatment early or don’t follow their treatment plan are more likely to develop AHD.
These three conditions collectively account for approximately 64% of AHD-related deaths.
AHD is diagnosed through screening a combination of:
1. CD4 Count: A CD4 count below 200 cells/mm³ is a key indicator of AHD.
2. Opportunistic Infections (OIs): The presence of diseases such as TB or certain cancers, which are common in people with AHD.
3. Other HIV-Related Conditions: Conditions like Kaposi Sarcoma, severe fungal infections, or chronic diarrhea may also indicate AHD.
Regular testing for CD4 count and viral load, along with screening for opportunistic infections, helps healthcare workers identify AHD early.
Without proper treatment, AHD can lead to higher rates of morbidity (illness) and mortality (death). People with AHD are more likely to develop severe infections that can overwhelm the body. Some of these infections, like TB, are more common in places with high HIV rates.
Global Impact:
Managing AHD involves a combination of treatments and supportive care. Early diagnosis and treatment are key to reducing complications and improving outcomes for people living with AHD.
Key management strategies include:
An integrated care approach—combining ART, treatment for OIs, and holistic care—is essential for managing AHD effectively.
The good news is that AHD is preventable. With early diagnosis and early ART initiation, people with HIV can avoid progressing to AHD.
To prevent AHD:
1. Get Tested Regularly: Regular HIV testing helps detect the virus early, allowing for immediate treatment.
2. Start ART Early: Begin antiretroviral therapy as soon as HIV is diagnosed. Starting treatment early helps prevent the immune system from weakening.
3. Adhere to Treatment: Consistently taking ART as prescribed can keep the virus under control and the immune system strong.
4. Regular Check-Ups: Regular monitoring of CD4 counts and viral load helps ensure the treatment is effective and makes adjustments when needed.
Add content above into a clickable infographic where users can explore the key interventions for managing AHD in detail.
Efforts to address Advanced HIV Disease (AHD) include initiatives like the IMPAACT4HIV Consortium, led by the Aurum Institute, and the THRIVE Consortium, led by the Clinton Health Access Initiative (CHAI). These consortia collaborate globally to provide evidence-based strategies, enhance service delivery, engage communities, and advocate for policy changes aimed at improving the prevention, care, and treatment of AHD.
For Healthcare Workers: Learn about the signs and symptoms of AHD, and start ART early for patients living with HIV. Regularly check CD4 counts and viral loads.
Clinical tools
For Communities: Advocate for HIV testing and ART access. Support people living with HIV by reducing stigma and providing mental health and nutritional support.
Community tools and training
For Policymakers: Ensure access to quality HIV care, including ART and treatment for opportunistic infections. Support research into new treatment options.
Generating Evidence
Together, we can reduce the burden of AHD and improve the lives of people living with HIV.
